loading...| Preferred Name |
Atorvastatin |
|
| Synonyms |
Atorvastatin Calcium Anhydrous |
|
| Definitions |
A pyrrole and heptanoic acid derivative, HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITOR (statin), and ANTICHOLESTEREMIC AGENT that is used to reduce serum levels of LDL-CHOLESTEROL; APOLIPOPROTEIN B; and TRIGLYCERIDES. It is used to increase serum levels of HDL-CHOLESTEROL in the treatment of HYPERLIPIDEMIAS, and for the prevention of CARDIOVASCULAR DISEASES in patients with multiple risk factors. |
|
| ID |
http://purl.bioontology.org/ontology/MESH/D000069059 |
|
| altLabel |
Atorvastatin Calcium Anhydrous (3R,5R)-7-(2-(4-Fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoic acid Atorvastatin Calcium Lipitor CI981 CI-981 Atorvastatin Calcium Trihydrate CI 981 Atorvastatin Calcium Hydrate Liptonorm Atorvastatin, Calcium Salt |
|
| AQL |
AA AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR |
|
| cui |
C2698195 C3463896 C0286651 C0593906 C3887698 C0286650 C0082029 |
|
| DC |
1 |
|
| definition |
A pyrrole and heptanoic acid derivative, HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITOR (statin), and ANTICHOLESTEREMIC AGENT that is used to reduce serum levels of LDL-CHOLESTEROL; APOLIPOPROTEIN B; and TRIGLYCERIDES. It is used to increase serum levels of HDL-CHOLESTEROL in the treatment of HYPERLIPIDEMIAS, and for the prevention of CARDIOVASCULAR DISEASES in patients with multiple risk factors. |
|
| DX |
20160101 |
|
| HN |
2019 (1990) |
|
| Inverse of AQ |
http://purl.bioontology.org/ontology/MESH/Q000097 http://purl.bioontology.org/ontology/MESH/Q000627 http://purl.bioontology.org/ontology/MESH/Q000493 http://purl.bioontology.org/ontology/MESH/Q000494 http://purl.bioontology.org/ontology/MESH/Q000276 http://purl.bioontology.org/ontology/MESH/Q000138 http://purl.bioontology.org/ontology/MESH/Q000134 http://purl.bioontology.org/ontology/MESH/Q000266 http://purl.bioontology.org/ontology/MESH/Q000378 http://purl.bioontology.org/ontology/MESH/Q000008 http://purl.bioontology.org/ontology/MESH/Q000009 http://purl.bioontology.org/ontology/MESH/Q000031 http://purl.bioontology.org/ontology/MESH/Q000032 http://purl.bioontology.org/ontology/MESH/Q000037 http://purl.bioontology.org/ontology/MESH/Q000191 http://purl.bioontology.org/ontology/MESH/Q000302 http://purl.bioontology.org/ontology/MESH/Q000145 http://purl.bioontology.org/ontology/MESH/Q000592 http://purl.bioontology.org/ontology/MESH/Q000737 http://purl.bioontology.org/ontology/MESH/Q000819 http://purl.bioontology.org/ontology/MESH/Q000506 http://purl.bioontology.org/ontology/MESH/Q000633 http://purl.bioontology.org/ontology/MESH/Q000600 |
|
| Inverse of RB |
C0GEJ5QCSO 48A5M73Z4Q A0JWA85V8F 0 |
|
| isa | ||
| LT |
TRD |
|
| Machine permutation |
2019; see ATORVASTATIN CALCIUM 2016-2018; ATORVASTATIN CALCIUM was indexed under HEPTANOIC ACIDS and PYRROLES 1990-2015 |
|
| Mapped from | ||
| MDA |
20150710 |
|
| MMR |
20180702 |
|
| MN |
D03.383.129.578.075 D10.251.450.200 |
|
| notation |
D000069059 |
|
| PA |
D019161 D000924 |
|
| prefLabel |
Atorvastatin |
|
| RR |
C0GEJ5QCSO 48A5M73Z4Q 110862-48-1 (Atorvastatin Calcium) |
|
| TERMUI |
T000878266 T209296 T000878269 T000878268 T000878267 T209298 T000940709 T000878264 T000878265 T209295 T000878270 |
|
| TH |
NLM (2016) FDA SRS (2018) NLM (1990) FDA SRS (2013) NLM (2019) USAN (1994) USAN (19XX) INN (19XX) NLM (2014) USP (19XX) |
|
| tui |
T109 T121 |
|
| subClassOf |